Global Emphysema Drug Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Emphysema Drug Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Emphysema Drug by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Emphysema Drug by Country/Region, 2017, 2022 & 2028

2.2 Emphysema Drug Segment by Type

2.2.1 BB-3

2.2.2 EDO-66

2.2.3 MG-53

2.2.4 Others

2.3 Emphysema Drug Sales by Type

2.3.1 Global Emphysema Drug Sales Market Share by Type (2017-2022)

2.3.2 Global Emphysema Drug Revenue and Market Share by Type (2017-2022)

2.3.3 Global Emphysema Drug Sale Price by Type (2017-2022)

2.4 Emphysema Drug Segment by Application

2.4.1 Hospital

2.4.2 Clinic

2.4.3 Others

2.5 Emphysema Drug Sales by Application

2.5.1 Global Emphysema Drug Sale Market Share by Application (2017-2022)

2.5.2 Global Emphysema Drug Revenue and Market Share by Application (2017-2022)

2.5.3 Global Emphysema Drug Sale Price by Application (2017-2022)

3 Global Emphysema Drug by Company

3.1 Global Emphysema Drug Breakdown Data by Company

3.1.1 Global Emphysema Drug Annual Sales by Company (2020-2022)

3.1.2 Global Emphysema Drug Sales Market Share by Company (2020-2022)

3.2 Global Emphysema Drug Annual Revenue by Company (2020-2022)

3.2.1 Global Emphysema Drug Revenue by Company (2020-2022)

3.2.2 Global Emphysema Drug Revenue Market Share by Company (2020-2022)

3.3 Global Emphysema Drug Sale Price by Company

3.4 Key Manufacturers Emphysema Drug Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Emphysema Drug Product Location Distribution

3.4.2 Players Emphysema Drug Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Emphysema Drug by Geographic Region

4.1 World Historic Emphysema Drug Market Size by Geographic Region (2017-2022)

4.1.1 Global Emphysema Drug Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Emphysema Drug Annual Revenue by Geographic Region

4.2 World Historic Emphysema Drug Market Size by Country/Region (2017-2022)

4.2.1 Global Emphysema Drug Annual Sales by Country/Region (2017-2022)

4.2.2 Global Emphysema Drug Annual Revenue by Country/Region

4.3 Americas Emphysema Drug Sales Growth

4.4 APAC Emphysema Drug Sales Growth

4.5 Europe Emphysema Drug Sales Growth

4.6 Middle East & Africa Emphysema Drug Sales Growth

5 Americas

5.1 Americas Emphysema Drug Sales by Country

5.1.1 Americas Emphysema Drug Sales by Country (2017-2022)

5.1.2 Americas Emphysema Drug Revenue by Country (2017-2022)

5.2 Americas Emphysema Drug Sales by Type

5.3 Americas Emphysema Drug Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Emphysema Drug Sales by Region

6.1.1 APAC Emphysema Drug Sales by Region (2017-2022)

6.1.2 APAC Emphysema Drug Revenue by Region (2017-2022)

6.2 APAC Emphysema Drug Sales by Type

6.3 APAC Emphysema Drug Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Emphysema Drug by Country

7.1.1 Europe Emphysema Drug Sales by Country (2017-2022)

7.1.2 Europe Emphysema Drug Revenue by Country (2017-2022)

7.2 Europe Emphysema Drug Sales by Type

7.3 Europe Emphysema Drug Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Emphysema Drug by Country

8.1.1 Middle East & Africa Emphysema Drug Sales by Country (2017-2022)

8.1.2 Middle East & Africa Emphysema Drug Revenue by Country (2017-2022)

8.2 Middle East & Africa Emphysema Drug Sales by Type

8.3 Middle East & Africa Emphysema Drug Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Emphysema Drug

10.3 Manufacturing Process Analysis of Emphysema Drug

10.4 Industry Chain Structure of Emphysema Drug

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Emphysema Drug Distributors

11.3 Emphysema Drug Customer

12 World Forecast Review for Emphysema Drug by Geographic Region

12.1 Global Emphysema Drug Market Size Forecast by Region

12.1.1 Global Emphysema Drug Forecast by Region (2023-2028)

12.1.2 Global Emphysema Drug Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Emphysema Drug Forecast by Type

12.7 Global Emphysema Drug Forecast by Application

13 Key Players Analysis

13.1 Angion Biomedica Corp.

13.1.1 Angion Biomedica Corp. Company Information

13.1.2 Angion Biomedica Corp. Emphysema Drug Product Offered

13.1.3 Angion Biomedica Corp. Emphysema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Angion Biomedica Corp. Main Business Overview

13.1.5 Angion Biomedica Corp. Latest Developments

13.2 ProMetic Life Sciences Inc.

13.2.1 ProMetic Life Sciences Inc. Company Information

13.2.2 ProMetic Life Sciences Inc. Emphysema Drug Product Offered

13.2.3 ProMetic Life Sciences Inc. Emphysema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 ProMetic Life Sciences Inc. Main Business Overview

13.2.5 ProMetic Life Sciences Inc. Latest Developments

13.3 rEVO Biologics, Inc.

13.3.1 rEVO Biologics, Inc. Company Information

13.3.2 rEVO Biologics, Inc. Emphysema Drug Product Offered

13.3.3 rEVO Biologics, Inc. Emphysema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 rEVO Biologics, Inc. Main Business Overview

13.3.5 rEVO Biologics, Inc. Latest Developments

13.4 SATT North SAS

13.4.1 SATT North SAS Company Information

13.4.2 SATT North SAS Emphysema Drug Product Offered

13.4.3 SATT North SAS Emphysema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 SATT North SAS Main Business Overview

13.4.5 SATT North SAS Latest Developments

13.5 TGV-Laboratories

13.5.1 TGV-Laboratories Company Information

13.5.2 TGV-Laboratories Emphysema Drug Product Offered

13.5.3 TGV-Laboratories Emphysema Drug Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 TGV-Laboratories Main Business Overview

13.5.5 TGV-Laboratories Latest Developments

14 Research Findings and Conclusion

Table 1. Emphysema Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Emphysema Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of BB-3

Table 4. Major Players of EDO-66

Table 5. Major Players of MG-53

Table 6. Major Players of Others

Table 7. Global Emphysema Drug Sales by Type (2017-2022) & (K Pcs)

Table 8. Global Emphysema Drug Sales Market Share by Type (2017-2022)

Table 9. Global Emphysema Drug Revenue by Type (2017-2022) & ($ million)

Table 10. Global Emphysema Drug Revenue Market Share by Type (2017-2022)

Table 11. Global Emphysema Drug Sale Price by Type (2017-2022) & (USD/Pcs)

Table 12. Global Emphysema Drug Sales by Application (2017-2022) & (K Pcs)

Table 13. Global Emphysema Drug Sales Market Share by Application (2017-2022)

Table 14. Global Emphysema Drug Revenue by Application (2017-2022)

Table 15. Global Emphysema Drug Revenue Market Share by Application (2017-2022)

Table 16. Global Emphysema Drug Sale Price by Application (2017-2022) & (USD/Pcs)

Table 17. Global Emphysema Drug Sales by Company (2020-2022) & (K Pcs)

Table 18. Global Emphysema Drug Sales Market Share by Company (2020-2022)

Table 19. Global Emphysema Drug Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Emphysema Drug Revenue Market Share by Company (2020-2022)

Table 21. Global Emphysema Drug Sale Price by Company (2020-2022) & (USD/Pcs)

Table 22. Key Manufacturers Emphysema Drug Producing Area Distribution and Sales Area

Table 23. Players Emphysema Drug Products Offered

Table 24. Emphysema Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Emphysema Drug Sales by Geographic Region (2017-2022) & (K Pcs)

Table 28. Global Emphysema Drug Sales Market Share Geographic Region (2017-2022)

Table 29. Global Emphysema Drug Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Emphysema Drug Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Emphysema Drug Sales by Country/Region (2017-2022) & (K Pcs)

Table 32. Global Emphysema Drug Sales Market Share by Country/Region (2017-2022)

Table 33. Global Emphysema Drug Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Emphysema Drug Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Emphysema Drug Sales by Country (2017-2022) & (K Pcs)

Table 36. Americas Emphysema Drug Sales Market Share by Country (2017-2022)

Table 37. Americas Emphysema Drug Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Emphysema Drug Revenue Market Share by Country (2017-2022)

Table 39. Americas Emphysema Drug Sales by Type (2017-2022) & (K Pcs)

Table 40. Americas Emphysema Drug Sales Market Share by Type (2017-2022)

Table 41. Americas Emphysema Drug Sales by Application (2017-2022) & (K Pcs)

Table 42. Americas Emphysema Drug Sales Market Share by Application (2017-2022)

Table 43. APAC Emphysema Drug Sales by Region (2017-2022) & (K Pcs)

Table 44. APAC Emphysema Drug Sales Market Share by Region (2017-2022)

Table 45. APAC Emphysema Drug Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Emphysema Drug Revenue Market Share by Region (2017-2022)

Table 47. APAC Emphysema Drug Sales by Type (2017-2022) & (K Pcs)

Table 48. APAC Emphysema Drug Sales Market Share by Type (2017-2022)

Table 49. APAC Emphysema Drug Sales by Application (2017-2022) & (K Pcs)

Table 50. APAC Emphysema Drug Sales Market Share by Application (2017-2022)

Table 51. Europe Emphysema Drug Sales by Country (2017-2022) & (K Pcs)

Table 52. Europe Emphysema Drug Sales Market Share by Country (2017-2022)

Table 53. Europe Emphysema Drug Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Emphysema Drug Revenue Market Share by Country (2017-2022)

Table 55. Europe Emphysema Drug Sales by Type (2017-2022) & (K Pcs)

Table 56. Europe Emphysema Drug Sales Market Share by Type (2017-2022)

Table 57. Europe Emphysema Drug Sales by Application (2017-2022) & (K Pcs)

Table 58. Europe Emphysema Drug Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Emphysema Drug Sales by Country (2017-2022) & (K Pcs)

Table 60. Middle East & Africa Emphysema Drug Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Emphysema Drug Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Emphysema Drug Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Emphysema Drug Sales by Type (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Emphysema Drug Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Emphysema Drug Sales by Application (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Emphysema Drug Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Emphysema Drug

Table 68. Key Market Challenges & Risks of Emphysema Drug

Table 69. Key Industry Trends of Emphysema Drug

Table 70. Emphysema Drug Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Emphysema Drug Distributors List

Table 73. Emphysema Drug Customer List

Table 74. Global Emphysema Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 75. Global Emphysema Drug Sales Market Forecast by Region

Table 76. Global Emphysema Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Emphysema Drug Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Emphysema Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 79. Americas Emphysema Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Emphysema Drug Sales Forecast by Region (2023-2028) & (K Pcs)

Table 81. APAC Emphysema Drug Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Emphysema Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Europe Emphysema Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Emphysema Drug Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Middle East & Africa Emphysema Drug Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Emphysema Drug Sales Forecast by Type (2023-2028) & (K Pcs)

Table 87. Global Emphysema Drug Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Emphysema Drug Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Emphysema Drug Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Emphysema Drug Sales Forecast by Application (2023-2028) & (K Pcs)

Table 91. Global Emphysema Drug Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Emphysema Drug Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Emphysema Drug Revenue Market Share Forecast by Application (2023-2028)

Table 94. Angion Biomedica Corp. Basic Information, Emphysema Drug Manufacturing Base, Sales Area and Its Competitors

Table 95. Angion Biomedica Corp. Emphysema Drug Product Offered

Table 96. Angion Biomedica Corp. Emphysema Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 97. Angion Biomedica Corp. Main Business

Table 98. Angion Biomedica Corp. Latest Developments

Table 99. ProMetic Life Sciences Inc. Basic Information, Emphysema Drug Manufacturing Base, Sales Area and Its Competitors

Table 100. ProMetic Life Sciences Inc. Emphysema Drug Product Offered

Table 101. ProMetic Life Sciences Inc. Emphysema Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 102. ProMetic Life Sciences Inc. Main Business

Table 103. ProMetic Life Sciences Inc. Latest Developments

Table 104. rEVO Biologics, Inc. Basic Information, Emphysema Drug Manufacturing Base, Sales Area and Its Competitors

Table 105. rEVO Biologics, Inc. Emphysema Drug Product Offered

Table 106. rEVO Biologics, Inc. Emphysema Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 107. rEVO Biologics, Inc. Main Business

Table 108. rEVO Biologics, Inc. Latest Developments

Table 109. SATT North SAS Basic Information, Emphysema Drug Manufacturing Base, Sales Area and Its Competitors

Table 110. SATT North SAS Emphysema Drug Product Offered

Table 111. SATT North SAS Emphysema Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 112. SATT North SAS Main Business

Table 113. SATT North SAS Latest Developments

Table 114. TGV-Laboratories Basic Information, Emphysema Drug Manufacturing Base, Sales Area and Its Competitors

Table 115. TGV-Laboratories Emphysema Drug Product Offered

Table 116. TGV-Laboratories Emphysema Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 117. TGV-Laboratories Main Business

Table 118. TGV-Laboratories Latest Developments

List of Figures

Figure 1. Picture of Emphysema Drug

Figure 2. Emphysema Drug Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Emphysema Drug Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Emphysema Drug Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Emphysema Drug Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of BB-3

Figure 10. Product Picture of EDO-66

Figure 11. Product Picture of MG-53

Figure 12. Product Picture of Others

Figure 13. Global Emphysema Drug Sales Market Share by Type in 2021

Figure 14. Global Emphysema Drug Revenue Market Share by Type (2017-2022)

Figure 15. Emphysema Drug Consumed in Hospital

Figure 16. Global Emphysema Drug Market: Hospital (2017-2022) & (K Pcs)

Figure 17. Emphysema Drug Consumed in Clinic

Figure 18. Global Emphysema Drug Market: Clinic (2017-2022) & (K Pcs)

Figure 19. Emphysema Drug Consumed in Others

Figure 20. Global Emphysema Drug Market: Others (2017-2022) & (K Pcs)

Figure 21. Global Emphysema Drug Sales Market Share by Application (2017-2022)

Figure 22. Global Emphysema Drug Revenue Market Share by Application in 2021

Figure 23. Emphysema Drug Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Emphysema Drug Revenue Market Share by Company in 2021

Figure 25. Global Emphysema Drug Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Emphysema Drug Revenue Market Share by Geographic Region in 2021

Figure 27. Global Emphysema Drug Sales Market Share by Region (2017-2022)

Figure 28. Global Emphysema Drug Revenue Market Share by Country/Region in 2021

Figure 29. Americas Emphysema Drug Sales 2017-2022 (K Pcs)

Figure 30. Americas Emphysema Drug Revenue 2017-2022 ($ Millions)

Figure 31. APAC Emphysema Drug Sales 2017-2022 (K Pcs)

Figure 32. APAC Emphysema Drug Revenue 2017-2022 ($ Millions)

Figure 33. Europe Emphysema Drug Sales 2017-2022 (K Pcs)

Figure 34. Europe Emphysema Drug Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Emphysema Drug Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Emphysema Drug Revenue 2017-2022 ($ Millions)

Figure 37. Americas Emphysema Drug Sales Market Share by Country in 2021

Figure 38. Americas Emphysema Drug Revenue Market Share by Country in 2021

Figure 39. United States Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Emphysema Drug Sales Market Share by Region in 2021

Figure 44. APAC Emphysema Drug Revenue Market Share by Regions in 2021

Figure 45. China Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Emphysema Drug Sales Market Share by Country in 2021

Figure 52. Europe Emphysema Drug Revenue Market Share by Country in 2021

Figure 53. Germany Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Emphysema Drug Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Emphysema Drug Revenue Market Share by Country in 2021

Figure 60. Egypt Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Emphysema Drug Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Emphysema Drug in 2021

Figure 66. Manufacturing Process Analysis of Emphysema Drug

Figure 67. Industry Chain Structure of Emphysema Drug

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles